Related Experiment Video
Updated: Oct 4, 2025

Osteoclast Derivation from Mouse Bone Marrow
Published on: November 6, 2014
Roles of LINC01473 and CD74 in osteoblasts in multiple myeloma bone disease
Fengping Peng1, Siyang Yan1, Hui Liu1
1Department of Hematology, Tianjin Medical University General Hospital, Tianjin, China.
Abstract:
The suppression of osteoblast (OB) activity is partially responsible for multiple myeloma (MM) bone disease. Long non-coding RNAs (lncRNAs) play a vital role in bone formation and resorption. However, their functions in OBs from patients with MM have rarely been reported. Through high-throughput sequencing of OBs from patients with MM and healthy controls, we identified several lncRNAs and messenger RNAs (mRNAs) with different expression profile and validated them using quantitative real-time PCR. In total, 22 upregulated and 21 downregulated lncRNAs were found in OBs from patients with MM. Moreover, 18 upregulated protein-coding mRNAs were identified. The expression levels of LINC01473 and its associated co-expression mRNA, CD74, were higher in patients with MM than in healthy controls (p=0.047 and p=0.016, respectively). LINC01473 expression demonstrated a negative correlation with serum interleukin-2 and tumor necrosis factor α levels, whereas the expression of mRNA CD74 was positively associated with serum lactic dehydrogenase in patients with MM. Aberrant expression of lncRNAs and mRNAs was observed in OBs from patients with MM. This study identifies new promising targets for further research on imbalanced bone formation and resorption and MM immune escape.
Insights
Multiple myeloma (MM) impairs bone health by suppressing osteoblast activity. This study identified specific long non-coding RNAs (lncRNAs) and messenger RNAs (mRNAs) with altered expression in MM patients, revealing potential therapeutic targets.
Area of Science:
- Molecular Biology
- Oncology
- Bone Biology
Background:
- Osteoblast (OB) dysfunction contributes to multiple myeloma (MM) bone disease.
- Long non-coding RNAs (lncRNAs) are crucial in bone metabolism, but their role in MM-associated OBs is understudied.
Purpose of the Study:
- To investigate the expression profiles of lncRNAs and messenger RNAs (mRNAs) in OBs from MM patients.
- To identify novel molecular targets for addressing bone abnormalities and immune evasion in MM.
Main Methods:
- High-throughput sequencing of OBs from MM patients and healthy controls.
- Validation of differentially expressed lncRNAs and mRNAs using quantitative real-time PCR.
Main Results:
- Identified 22 upregulated and 21 downregulated lncRNAs in MM OBs.
- Discovered 18 upregulated protein-coding mRNAs.
- Found elevated LINC01473 and CD74 expression in MM patients, with specific correlations to serum inflammatory markers and lactate dehydrogenase.
Conclusions:
- Aberrant lncRNA and mRNA expression in OBs from MM patients suggests a role in disease pathogenesis.
- LINC01473 and CD74 are potential biomarkers and therapeutic targets for MM bone disease and immune escape.
Related Concept Videos
Osteoclasts in Bone Remodeling
Bone Cells and Tissue
Osteoblasts and Osteocytes
The osteoblast is the bone cell responsible for forming new bone tissue. It is found in the growing portions of bone, including the...
Bone Remodeling

